Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats
PaperCitations, authors & open-access status
Empagliflozin, an SGLT2 Inhibitor, Reduced the Mortality Rate after Acute Myocardial Infarction with Modification of Cardiac Metabolomes and Antioxidants in Diabetic Rats is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 129 citations, 2018 year and bronze oa status.
129
Citations
2018
Year
bronze
OA Status